Cargando…

Editorial: The role of immunotherapy in melanomas

Detalles Bibliográficos
Autores principales:	Fateeva, Anna, Chen, Suzie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569413/ https://www.ncbi.nlm.nih.gov/pubmed/37841439 http://dx.doi.org/10.3389/fonc.2023.1293040

Ejemplares similares

Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
por: Guida, Michele, et al.
Publicado: (2022)

Editorial: Role of pigmentation in melanoma
por: Brożyna, Anna A., et al.
Publicado: (2022)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Genetics of melanoma
por: Wangari-Talbot, Janet, et al.
Publicado: (2013)

Editorial: Personalized immunotherapy for cancer
por: Pasetto, Anna, et al.
Publicado: (2023)

Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities
por: Eddy, Kevinn, et al.
Publicado: (2021)

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors
por: Ugel, Stefano, et al.
Publicado: (2023)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018)

Editorial: Imaging assessment of response to immunotherapy
por: Occhipinti, Mariaelena, et al.
Publicado: (2023)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: The Biological Landscape of Immunotherapy in AML
por: Isidori, Alessandro, et al.
Publicado: (2021)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Editorial: Engineered Targeted Cancer Immunotherapies
por: Fantini, Massimo, et al.
Publicado: (2022)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Editorial: Microbiota and metabolites in cancer immunotherapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Editorial: Combination Strategies in the Treatment of Melanoma
por: Ascierto, Paolo Antonio
Publicado: (2016)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
por: Santich, Brian H., et al.
Publicado: (2020)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Editorial: Emerging engineering approaches in cancer immunotherapy
por: Xu, Jialu, et al.
Publicado: (2022)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Research landscape and trends of melanoma immunotherapy: A bibliometric analysis
por: Liu, Yanhao, et al.
Publicado: (2023)

Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
por: Rohatgi, Anjali, et al.
Publicado: (2021)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect
por: Zhang, Xinyue, et al.
Publicado: (2022)

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
por: Yang, Jieying, et al.
Publicado: (2023)

Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
por: Qian, Yawei, et al.
Publicado: (2023)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Tolba, Mai F., et al.
Publicado: (2021)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
por: Thornton, Jessica, et al.
Publicado: (2022)

Immunotherapy for ocular melanoma: a bibliometric and visualization analysis from 1991 to 2022
por: Tan, Yao, et al.
Publicado: (2023)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023)

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
por: Al-Rajabi, Taiseer, et al.
Publicado: (2023)

Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications
por: Abedalthagafi, Malak
Publicado: (2021)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
por: Guo, Zhanjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ituq938n1rh00mhlcpmqe5kqgl